Ignite Creation Date:
2024-05-05 @ 11:40 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00101348
Status:
COMPLETED
Last Update Posted:
2014-06-11
First Post:
2005-01-07
Brief Title:
Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Colorectal Head and Neck Pancreatic or Non-Small Cell Lung Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-01
Start Date Type:
None
Primary Completion Date:
2007-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-05
Completion Date Type:
ACTUAL
First Submit Date:
2005-01-07
First Submit QC Date:
January 7 2005
Study First Post Date:
2005-01-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-06-10
Last Update Post Date:
2014-06-11
Last Update Post Date Type:
ESTIMATED